250 related articles for article (PubMed ID: 19929591)
1. Short- and long-term efficacy and safety of duloxetine in women with predominant stress urinary incontinence.
Cardozo L; Lange R; Voss S; Beardsworth A; Manning M; Viktrup L; Zhao YD
Curr Med Res Opin; 2010 Feb; 26(2):253-61. PubMed ID: 19929591
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and safety of duloxetine in elderly women with stress urinary incontinence or stress-predominant mixed urinary incontinence.
Schagen van Leeuwen JH; Lange RR; Jonasson AF; Chen WJ; Viktrup L
Maturitas; 2008 Jun; 60(2):138-47. PubMed ID: 18547757
[TBL] [Abstract][Full Text] [Related]
3. Duloxetine vs placebo in the treatment of stress urinary incontinence: a four-continent randomized clinical trial.
Millard RJ; Moore K; Rencken R; Yalcin I; Bump RC;
BJU Int; 2004 Feb; 93(3):311-8. PubMed ID: 14764128
[TBL] [Abstract][Full Text] [Related]
4. Duloxetine versus placebo for the treatment of North American women with stress urinary incontinence.
Dmochowski RR; Miklos JR; Norton PA; Zinner NR; Yalcin I; Bump RC;
J Urol; 2003 Oct; 170(4 Pt 1):1259-63. PubMed ID: 14501737
[TBL] [Abstract][Full Text] [Related]
5. Duloxetine versus placebo in the treatment of European and Canadian women with stress urinary incontinence.
van Kerrebroeck P; Abrams P; Lange R; Slack M; Wyndaele JJ; Yalcin I; Bump RC;
BJOG; 2004 Mar; 111(3):249-57. PubMed ID: 14961887
[TBL] [Abstract][Full Text] [Related]
6. Long-term efficacy of duloxetine in women with stress urinary incontinence.
Bump RC; Voss S; Beardsworth A; Manning M; Zhao YD; Chen W
BJU Int; 2008 Jul; 102(2):214-8. PubMed ID: 18422764
[TBL] [Abstract][Full Text] [Related]
7. Duloxetine versus placebo for the treatment of women with stress predominant urinary incontinence in Taiwan: a double-blind, randomized, placebo-controlled trial.
Lin AT; Sun MJ; Tai HL; Chuang YC; Huang ST; Wang N; Zhao YD; Beyrer J; Wulster-Radcliffe M; Levine L; Chang C; Viktrup L
BMC Urol; 2008 Jan; 8():2. PubMed ID: 18221532
[TBL] [Abstract][Full Text] [Related]
8. Duloxetine compared with placebo for the treatment of women with mixed urinary incontinence.
Bent AE; Gousse AE; Hendrix SL; Klutke CG; Monga AK; Yuen CK; Muram D; Yalcin I; Bump RC
Neurourol Urodyn; 2008; 27(3):212-21. PubMed ID: 17580357
[TBL] [Abstract][Full Text] [Related]
9. Duloxetine for mild to moderate postprostatectomy incontinence: preliminary results of a randomised, placebo-controlled trial.
Cornu JN; Merlet B; Ciofu C; Mouly S; Peyrat L; Sèbe P; Yiou R; Vallancien G; Debrix I; Laribi K; Cussenot O; Haab F
Eur Urol; 2011 Jan; 59(1):148-54. PubMed ID: 21030144
[TBL] [Abstract][Full Text] [Related]
10. Duloxetine versus placebo in the treatment of stress urinary incontinence.
Norton PA; Zinner NR; Yalcin I; Bump RC;
Am J Obstet Gynecol; 2002 Jul; 187(1):40-8. PubMed ID: 12114886
[TBL] [Abstract][Full Text] [Related]
11. Serotonin and noradrenaline reuptake inhibitors (SNRI) for stress urinary incontinence in adults.
Mariappan P; Ballantyne Z; N'Dow JM; Alhasso AA
Cochrane Database Syst Rev; 2005 Jul; (3):CD004742. PubMed ID: 16034945
[TBL] [Abstract][Full Text] [Related]
12. Duloxetine in the treatment of women with stress urinary incontinence: results from DESIRE (Duloxetine Efficacy and Safety for Incontinence in Racial and Ethnic populations).
Weinstein DL; Cohen JS; Liu C; Meadows ES; Plouffe L; Muram D;
Curr Med Res Opin; 2006 Nov; 22(11):2121-9. PubMed ID: 17076972
[TBL] [Abstract][Full Text] [Related]
13. Pharmacological treatment of women awaiting surgery for stress urinary incontinence.
Cardozo L; Drutz HP; Baygani SK; Bump RC
Obstet Gynecol; 2004 Sep; 104(3):511-9. PubMed ID: 15339761
[TBL] [Abstract][Full Text] [Related]
14. Duloxetine: a new approach for treating stress urinary incontinence.
Moore K
Int J Gynaecol Obstet; 2004 Jul; 86 Suppl 1():S53-62. PubMed ID: 15302567
[TBL] [Abstract][Full Text] [Related]
15. Duloxetine treatment of stress urinary incontinence in women: effects of demographics, obesity, chronic lung disease, hypoestrogenism, diabetes mellitus, and depression on efficacy.
Viktrup L; Yalcin I
Eur J Obstet Gynecol Reprod Biol; 2007 Jul; 133(1):105-13. PubMed ID: 16769171
[TBL] [Abstract][Full Text] [Related]
16. Effect of dose escalation on the tolerability and efficacy of duloxetine in the treatment of women with stress urinary incontinence.
Castro-Diaz D; Palma PC; Bouchard C; Haab F; Hampel C; Carone R; Zepeda Contreras S; Rodriguez Ginorio H; Voss S; Yalcin I; Bump RC;
Int Urogynecol J Pelvic Floor Dysfunct; 2007 Aug; 18(8):919-29. PubMed ID: 17160693
[TBL] [Abstract][Full Text] [Related]
17. Duloxetine: a review of its use in the treatment of generalized anxiety disorder.
Carter NJ; McCormack PL
CNS Drugs; 2009; 23(6):523-41. PubMed ID: 19480470
[TBL] [Abstract][Full Text] [Related]
18. How are women with SUI-symptoms treated with duloxetine in real life practice? - preliminary results from a large observational study in Germany.
Manning M; Gotsch U; Minarzyk A; Quail D; Gross A; Pages I; Methfessel HD; Michel MC
Int J Clin Pract; 2009 Dec; 63(12):1724-33. PubMed ID: 19930333
[TBL] [Abstract][Full Text] [Related]
19. Duloxetine for the treatment of major depressive disorder: a closer look at efficacy and safety data across the approved dose range.
Mallinckrodt CH; Prakash A; Andorn AC; Watkin JG; Wohlreich MM
J Psychiatr Res; 2006 Jun; 40(4):337-48. PubMed ID: 16271726
[TBL] [Abstract][Full Text] [Related]
20. Duloxetine, a serotonin and noradrenaline reuptake inhibitor (SNRI) for the treatment of stress urinary incontinence: a systematic review.
Mariappan P; Alhasso A; Ballantyne Z; Grant A; N'Dow J
Eur Urol; 2007 Jan; 51(1):67-74. PubMed ID: 17014950
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
